BRPI0913630A2 - solid dosage pharmaceutical formulation and, amorphous form of compound - Google Patents
solid dosage pharmaceutical formulation and, amorphous form of compoundInfo
- Publication number
- BRPI0913630A2 BRPI0913630A2 BRPI0913630A BRPI0913630A BRPI0913630A2 BR PI0913630 A2 BRPI0913630 A2 BR PI0913630A2 BR PI0913630 A BRPI0913630 A BR PI0913630A BR PI0913630 A BRPI0913630 A BR PI0913630A BR PI0913630 A2 BRPI0913630 A2 BR PI0913630A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical formulation
- solid dosage
- amorphous form
- dosage pharmaceutical
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16654208P | 2008-06-30 | 2008-06-30 | |
PCT/US2009/049009 WO2010002763A1 (en) | 2008-06-30 | 2009-06-29 | Solid dosage formulations of telcagepant potassium |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0913630A2 true BRPI0913630A2 (en) | 2015-10-27 |
Family
ID=54541582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0913630A BRPI0913630A2 (en) | 2008-06-30 | 2009-06-29 | solid dosage pharmaceutical formulation and, amorphous form of compound |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0913630A2 (en) |
-
2009
- 2009-06-29 BR BRPI0913630A patent/BRPI0913630A2/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0906467A2 (en) | pharmaceutical dosage form | |
DK2346495T4 (en) | PHARMACEUTICAL FORMULATION 514 | |
SMT201400069B (en) | Pharmaceutical formulation | |
BRPI0906962A2 (en) | Compound and pharmaceutical composition | |
BRPI0906556A2 (en) | Compound and pharmaceutical composition | |
ZA201005015B (en) | Solid pharmaceutical dosage form | |
IT1394860B1 (en) | PHARMACEUTICAL COMPOUNDS | |
BRPI0912026A2 (en) | homeopathic formulation | |
BRPI0908132A2 (en) | Benzodiazepine Compound and Pharmaceutical Composition | |
BRPI0921654A2 (en) | pharmaceutical formulation | |
BRPI0917681A2 (en) | Compound and pharmaceutical composition | |
BRPI0922804A2 (en) | solid dosage forms of bendamustine | |
DK2285413T3 (en) | Pharmaceutical composition | |
BRPI0807078A2 (en) | COMPOUND AND PHARMACEUTICAL FORMULATION | |
DK2285359T3 (en) | Solid form drug formulation with delayed excretion | |
BR112012000831A2 (en) | related compounds, pharmaceutical compositions and methods | |
BRPI0922806A2 (en) | bendamustine oral dosage forms | |
BRPI0921313A2 (en) | pharmaceutical composition | |
BRPI0812964A2 (en) | SOLID ORAL PHARMACEUTICAL DOSAGE FORM | |
DK2271618T3 (en) | Pharmaceutical compounds | |
DK2391351T3 (en) | Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives | |
BR112012031102A2 (en) | solid oral dosage form | |
IT1393930B1 (en) | PHARMACEUTICAL COMPOUNDS | |
BR112012015016A2 (en) | pharmaceutical formulation and enteric pharmaceutical dosage form | |
BRPI0818702A2 (en) | Pharmaceutical formulation of clavulanic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |